|
1. |
Schizophrenia: a Study of Genetic Models and some of Their Implications |
|
Neuropsychobiology,
Volume 4,
Issue 5,
1978,
Page 257-269
Quentin Debray,
Vincent Caillard,
John Stewart,
Preview
|
PDF (1407KB)
|
|
摘要:
The likelihoods of observing 25 four-generational families of schizophrenics comprising 1,333 individuals have been calculated on the basis of 12 different genetic models and one control ‘sporadic’ model. The control model gave a log10 likelihood, L, of –240.92. Five of the genetic models were definitely excluded as incompatible with certain pedigrees. The three models with the highest likelihoods were: one locus, the heterozygote having a 10% probability of being classified schizophrenic (L: –220.05); two interacting loci (L: –219.46), and four polygenes (L:
ISSN:0302-282X
DOI:10.1159/000117639
出版商:S. Karger AG
年代:1978
数据来源: Karger
|
2. |
Thyroid Autoantibody Levels during Lithium Therapy |
|
Neuropsychobiology,
Volume 4,
Issue 5,
1978,
Page 270-275
P. Deniker,
A. Eyquem,
R. Bernheim,
H. Loo,
P. Delarue,
Preview
|
PDF (672KB)
|
|
摘要:
The study of the levels of thyroid antibodies was conducted in 58 patients treated with lithium and in 40 subjects who received other psychotropic drugs and who were used as controls. The measure of the antithyroglobulin antibodies was made by passive hemagglutination and that of the antimicrosomal antibodies by indirect immunofluorescence. For the whole control group, the research of the antithyroglobulin antibodies was positive in 3 cases, i.e. 7.5%. For the 58 patients treated with lithium, this research was positive in 11 subjects, i.e. 19%: thus, lithium seems to cause immunological reactions in the thyroid. 5 lithium-treated patients developed a goiter. The antibody determination was positive in only 2 subjects and was negative in the others. The measure of antithyroid antibodies before lithium did not enable us to predict the emergence of thyroid complications. On the contrary, subjects treated with lithium presented significantly high antibody levels without developing clinical thyroid manifestations.
ISSN:0302-282X
DOI:10.1159/000117640
出版商:S. Karger AG
年代:1978
数据来源: Karger
|
3. |
Genetic Markers in Cycloid Psychosis |
|
Neuropsychobiology,
Volume 4,
Issue 5,
1978,
Page 276-282
G. Beckman,
L. Beckman,
B. Cedergren,
C. Perris,
E. Strandman,
L. Wählby,
Preview
|
PDF (671KB)
|
|
摘要:
Frequencies of HLA antigens, blood groups, serum groups and red cell enzyme types in patients with cycloid psychosis were compared with those in patients with bipolar psychosis and in normal controls. Patients with cycloid psychosis showed (1) an increased frequency of the Rh-negative type compared to controls, (2) an increased frequency of the K(+) phenotype compared to both bipolar patients and controls, and (3) an increased frequency of the serum group Gc 2–
ISSN:0302-282X
DOI:10.1159/000117641
出版商:S. Karger AG
年代:1978
数据来源: Karger
|
4. |
The Treatment of Anxiety with a Polyfluorinated Benzodiazepine Derivative |
|
Neuropsychobiology,
Volume 4,
Issue 5,
1978,
Page 283-287
John T. Kelly,
Robert L. Zimmerman,
Burtrum C. Schiele,
Preview
|
PDF (562KB)
|
|
摘要:
Following 4 weeks of treatment with ORF-8063 a polyfluorinated benzodiazepine derivative, 8 hospitalized patients manifesting a primary pathology of anxiety showed marked general improvement. 2 other persons were treated, but for shorter periods: 9 and 14 days. Both are included in the pre-post analysis. Mean optimal dosage was 66.5 mg. The five instruments used to measure therapeutic effect showed pre- to posttreatment change with high level of statistical significance in several of the pathological factors. When measures of change are considered, patients showed more improvement related to psychic than somatic components of anxiety. Change data also indicates more patient improvement in anxiety than depression. Side effects reported most were dizziness, faintness and insomnia; these were reported in 8 patients. 6 patients noted drowsiness, and 4 noted excitement. 5 persons tolerated optimum dosages with no extreme reactions; 5 others (including the 2 subjects who terminated treatment early) were unable to maintain optimum dosages because of side effects.
ISSN:0302-282X
DOI:10.1159/000117642
出版商:S. Karger AG
年代:1978
数据来源: Karger
|
5. |
Nosological and Prognostic Distinctions in Schizophrenia: Pharmacological Validation in Terms of Therapeutic Antagonism between Anticholinergic Anti-Parkinsonism Drugs and Neuroleptics |
|
Neuropsychobiology,
Volume 4,
Issue 5,
1978,
Page 288-304
Man Mohan Singh,
Stanley R. Kay,
Preview
|
PDF (2169KB)
|
|
摘要:
In studying the relationships between anticholinergic-neuroleptic interactions and the nosological and prognostic distinctions in schizophrenia, we have shown that these distinctions have clinicopathological meaning. The countertherapeutic anticholinergic effects seemed to be particularly evident in the good outcome, schizophreniform cases and differentiated between the three diagnostic subtypes. Such effects were most conspicuous in the catatonics who also had the most favorable prognosis, while the paranoids differed from others in not only showing the least anticholinergic effects but also in not conforming to the relationship between these effects and prognosis. The findings are briefly considered in relation to those with wheat gluten which has also been shown to be a countertherapeutic factor in schizophrenia in another study.
ISSN:0302-282X
DOI:10.1159/000117643
出版商:S. Karger AG
年代:1978
数据来源: Karger
|
6. |
Pharmacokinetic Interaction between Amitriptyline and Neuroleptics |
|
Neuropsychobiology,
Volume 4,
Issue 5,
1978,
Page 305-313
A. Jus,
J. Gautier,
A. Villeneuve,
K. Jus,
P. Pires,
M. Gagnon-Binette,
C. Fortin,
Preview
|
PDF (942KB)
|
|
摘要:
The influence of amitriptyline on the plasma level of various neuroleptics was studied in 25 chronic schizophrenic patients. The study lasted 20 weeks. Patients were kept first 4 weeks on their former neuroleptic medication, with amitriptyline added for 12 subsequent weeks, and withdrawn during the last 4 weeks when only the neuroleptic medication was continued unchanged. The plasma level of neuroleptics was assayed by gas-liquid chromatography, once weekly throughout the study. The amitriptyline plasma level was also evaluated once weekly during the 12 weeks of its administration. The mean neuroleptic plasma values for each 4-week period were pooled together in three groups: aliphatic, piperidine and piperazine phenothiazine derivatives. Amitriptyline provoked some increase of the plasma level of all phenothiazine derivatives. This augmentation was significant only transitorily, however. The putative mechanisms of this neuroleptic tricyclic antidepressant interaction are discussed.
ISSN:0302-282X
DOI:10.1159/000117644
出版商:S. Karger AG
年代:1978
数据来源: Karger
|
7. |
Visual Averaged Evoked Responses in Patients with Bipolar Affective Disorders |
|
Neuropsychobiology,
Volume 4,
Issue 5,
1978,
Page 314-320
L. von Knorring,
Preview
|
PDF (768KB)
|
|
摘要:
19 patients with bipolar affective disorders were investigated with visual averaged evoked responses (V.AER) to different stimulus intensities. 7 patients were investigated only in the depressive phase, 8 only in the manic phase, 2 in both the depressive and the manic phase, 1 in the manic phase and after recovery, and 1 patient was followed in both the depressive and the manic phase and when recovered. Both the comparisons between the independent groups and the results from the individual patients followed in different phases of the disorder indicate that patients in the depressive phase have a tendency to decrease in maximum amplitude when stimulus intensity is increased (reducing). Patients in the manic phase, on the other hand, show increasing maximum amplitude with increasing stimulus intensity (augmenting). The biochemical basis for this switch in augmenting/reducing tendency seem to be changes in the activity in the monoaminergic systems.
ISSN:0302-282X
DOI:10.1159/000117645
出版商:S. Karger AG
年代:1978
数据来源: Karger
|
|